Store besparelser
Hurtig levering
Gemte
Log ind
0
Kurv
Kurv
Benefit-Risk Assessment of Medicines
- The Development and Application of a Universal Framework for Decision-Making and Effective Communication
Engelsk Hardback
Benefit-Risk Assessment of Medicines
- The Development and Application of a Universal Framework for Decision-Making and Effective Communication
Engelsk Hardback

478 kr
Tilføj til kurv
Sikker betaling
6 - 8 hverdage

Om denne bog

This book proposes and investigates a universal framework, and accompanying documentation system, to facilitate and catalogue benefit-risk decisions; a valuable addition to the benefit-risk toolbox.

Over the past decade, pharmaceutical companies and regulatory agencies have been reviewing the benefit-risk assessment of medicines with a view to developing a structured, systematic, standardized approach. Examining the evaluation of such an approach by several mature regulatory authorities ensures that the reader gains a unique insight into the ongoing debate in this area.

The field of benefit-risk assessment continues to evolve at a rapid pace due to political and societal pressure, as is reflected in the recent FDA PUDFA agreement as well as in the EMA 2015 Roadmap. Rather than provide a comprehensive snap-shot of this constantly changing environment, this book evaluates selected current approaches to benefit-risk assessment. The strengths and weaknesses of publicly available documents in communicating benefit-risk decisions to stakeholders are reviewed and these evaluations are used to inform development of a prospective framework that could be used to harmonise procedures globally.
Product detaljer
Sprog:
Engelsk
Sider:
317
ISBN-13:
9783319158044
Indbinding:
Hardback
Udgave:
ISBN-10:
331915804X
Udg. Dato:
5 maj 2015
Længde:
25mm
Bredde:
168mm
Højde:
244mm
Forlag:
Springer International Publishing AG
Oplagsdato:
5 maj 2015
Kategori sammenhænge